Artelo Biosciences Inc.-CW24ARTLWPreferred / convertible
13F holders, Q1 2024 (March 31)5holders
$0.02avg. 13F price*
At the end of Q1 2024, 5 institutions reported holding Artelo Biosciences Inc.-CW24 (ARTLW) in their 13F filings. The largest holders were Verition Fund Management LLC ($440), Alpine Global Management, LLC ($226) and UBS Group AG ($75).
- Company
- Artelo Biosciences Inc.-CW24
- CUSIP
- 04301G128
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $79 |
| Exits | 0 | $0 |
Ownership 5 holders
| Verition Fund Management LLC | — | No change | 27,299 | $440 |
| Alpine Global Management, LLC | — | No change | 14,099 | $226 |
| UBS Group AG | — | New | 4,697 | $75 |
| Bank of America Corp. | — | New | 274 | $4 |
| Morgan Stanley | — | No change | 162 | $3 |
"% of holder's portfolio" is ARTLW's weight in each manager's 13F, not the share of Artelo Biosciences Inc.-CW24 the manager owns.